2024 Optimal Resources for Breast Care

On behalf of the American College of Surgeons, Cancer Programs, it is our pleasure to welcome you to the Optimal Resources for Breast Care 2024 (NAPBC standards) course. During this course we will discuss how we place the patient in the center of the breast center programs by focusing on the patient journey. The new and revised standards set new requirements for the structure and operation of the NAPBC accredited breast centers that reinforces the vision and value of patient centered care. During this course, the NAPBC leaders and ACS staff will provide an in-depth review the development of the standards, discuss the new requirements and implementation process designed to assist the programs with transition, and outline the changes to the accreditation process that will assess the breast center’s focus on the patient journey.

Target Audience

  • Breast Program Directors
  • Breast Program Administrators
  • Breast Program Leadership Committee members
  • Physicians (diagnostic radiologists, pathologists, surgeons, medical oncologists, radiation oncologists)
  • Physician Assistants
  • Advanced Practice Providers
  • Navigators
  • Nurses
  • Occupational Therapists
  • Physical Therapists
  • Genetic Counselors
  • Cancer Registrars

Learning Objectives

  • Outline the experience of centers participating in the pilot site visit process and the important lessons learned.
  • Discuss the requirements for the new NAPBC accreditation standards, Optimal Resources for Breast Care, and how they apply to their accredited center.
  • Describe the implementation process for the standards and design a strategy to prepare their accredited center for a successful accreditation outcome.

Contact

  • For questions about the course, please contact cancerprogramevents@facs.org.
  • If you have any technical questions, contact elearning@facs.org
Course summary
Available credit: 
  • 3.50 AMA PRA Category 1 Credit™
  • 3.50 CE Contact hours
  • 3.50 Certificate of Completion
Course opens: 
05/31/2024
Course expires: 
12/31/2024
Cost:
$100.00

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Speakers / Moderators / Discussants / Authors

Oluwamuyiwa Adebayo - (Nothing to Disclose)               
Erika Akers - (Nothing to Disclose)              
Arslan Amir - (Nothing to Disclose)              
Carrie Antonelli - (Nothing to Disclose)               
Elliot Asare - (Nothing to Disclose)           
Maria Louise Avenido - (Nothing to Disclose)               
Carol-Ann Benn    - (Nothing to Disclose)               
Aaron Bleznak- (Nothing to Disclose)               
Daniel Boffa - Iovance , Epic Sciences, to attend and advisory panel  meeting collaboration, stipend, they ran experiments for free
Jessica Brandt - (Nothing to Disclose)               
Vicki Chiappetta - (Nothing to Disclose)          
Erin Collins-Buchanan- (Nothing to Disclose)               
Carolyn Compton - (Nothing to Disclose)          
Celeste Cruz- (Nothing to Disclose)               
Ian Csencsits - (Nothing to Disclose)          
Viktoriia Dailey    - (Nothing to Disclose)               
Edward Diaz - (Nothing to Disclose)               
Lauren Dori - (Nothing to Disclose)               
Lesly Dossett - (Nothing to Disclose)               
Brian Edwards - (Nothing to Disclose)               
Linda Farkas- (Nothing to Disclose)               
Marie Fefferman - (Nothing to Disclose)          
Emmanuel Gabriel - (Nothing to Disclose)               
Christine Garcia     Pfizer, honorarium, speaker
Sharon Gentry - (Nothing to Disclose)               
Richard Glick - (Nothing to Disclose)               
Brianna Graham - (Nothing to Disclose)               
James Gulley - (Nothing to Disclose)               
Emmy Hammons - (Nothing to Disclose)               
Victoria Haney - (Nothing to Disclose)               
Dawn Hayes - (Nothing to Disclose)               
Susan Hedlund - (Nothing to Disclose)               
Tina Hieken - (Nothing to Disclose)               
Suzanne Hoekstra - (Nothing to Disclose)               
Vanessa Hoffmann - (Nothing to Disclose)               
Mallori Hooker    - (Nothing to Disclose)               
Kyuseok Im - (Nothing to Disclose)               
Lauren Janczewski - (Nothing to Disclose)               
Paul Jeffers - (Nothing to Disclose)               
Kendra Johnson     - (Nothing to Disclose)               
Edward Joseph - (Nothing to Disclose)               
Rachel Joung - (Nothing to Disclose)               
Lyndsey Kilgore    - (Nothing to Disclose)               
Laurie Kirstein - (Nothing to Disclose)               
Michelle Kondracki - (Nothing to Disclose)               
Abha Kulkarni - (Nothing to Disclose)               
Ron Landmann- Ethicon, Natera    Consulting fees, consulting fees    consultant, consultant
Meeghan Lautner- (Nothing to Disclose)               
Raymond Liu Genentech, AstraZeneca, Exact Sciences, Biotheranostics, Beigene, Pfizer.research grant, research grant, research grant, research grant, research grant, think tank committee member    research grant, research grant, research grant, research grant, research grant, no honorarium, Sponsor provided travel lodging expenses for think tank
Denise Lutkemeier - (Nothing to Disclose)               
Heather Lyu - (Nothing to Disclose)               
Jenna Mancinelli - (Nothing to Disclose)           
Linda Martin Astrazeneca, Genentech, Ethicon, Ontarget laboratories honraria; investigator support, honoraria, honoraria, honoraria    Advisory board; principle investigator, advisory board; speaker’s bureau, speakers bureau, consulting; investigator for clinical trial
Hassan Masoudpoor - (Nothing to Disclose)               
Ryan McCabe - (Nothing to Disclose)               
James McLoughlin - (Nothing to Disclose)               
Stacey Milan - (Nothing to Disclose)               
Kimberly Miller    - (Nothing to Disclose)               
Kelsey Montgomery - (Nothing to Disclose)          
Gloria Morris - (Nothing to Disclose)               
Timothy  Mullett – oncolens, ownership, interest advisor
David Mullins - (Nothing to Disclose)               
Shelby Murphy    - (Nothing to Disclose)               
Daniella Natanov - (Nothing to Disclose)               
Toan Thien (Tony) Nguyen -aptitude health, consultant fee, consultant   
Jamie Partlow - (Nothing to Disclose)               
LeAnn Perkins - (Nothing to Disclose)               
Garrett Peters - (Nothing to Disclose)               
Lindsey Pimentel - (Nothing to Disclose)               
Broc Pollinger - (Nothing to Disclose)               
Marcella Ramahi - (Nothing to Disclose)               
ERIN REUTER- (Nothing to Disclose)               
Jonathan Rubin    - (Nothing to Disclose)               
Shayla Scarlett - 3M, individual stock owner of 10 shares in retirement account    N/A
Camille Servodidio -- (Nothing to Disclose)               
Charles Shelton    - (Nothing to Disclose)               
MOHUMMAD SIDDIQUI    - (Nothing to Disclose)           
Nicole Sinclair - (Nothing to Disclose)               
Rebecca A.  Snyder- (Nothing to Disclose)               
Jessica Steadman - (Nothing to Disclose)               
Amalia Stefanou - (Nothing to Disclose)               
James Sun - (Nothing to Disclose)               
Magesh Sundaram - (Nothing to Disclose)               
Chad Teven - (Nothing to Disclose)               
Whittney Thoman - (Nothing to Disclose)               
Stephanie Thomas - (Nothing to Disclose)               
Danielle Thompson - (Nothing to Disclose)               
Theodoros Voloyiannis    - (Nothing to Disclose)               
Mark Whiteford - (Nothing to Disclose)    
Lee Wilke -Elucent medical, perimeter medical, Stock options (less than 5%), Institutional support for clinical trial, Founder, instutional PI of clinical trial- no salary support
Chris Wilson- (Nothing to Disclose)               
Emma Zimmerman- (Nothing to Disclose)
Judy Boughey, MBBChir, FACS - Cairns Surgical, SymBioSys, Physicians Education Resource (PER)
PeerView, EndoMag, research support to my institution for clinical trial, financial support for time spent on data safety monitoring committee, royalty share for co-developed IP, honorarium, honorarium, honorarium, Co-PI, member of DSMC, collaboration speaker at educational conference, speaker at educational conference, speaker at educational conference
Katherine Yao, MD, FACS - (Nothing to Disclose)    
Kinberly Yee, MD, FACS    - (Nothing to Disclose)
Mediget Teshome, MD, FACS – Endomagnetics travel/accommodations for TBCC22 conference    speaker
Elizabeth Wick, MD, FACS - (Nothing to Disclose)        
Ronald Weigel, MD, FACS - (Nothing to Disclose)    
Anthony Yang, MD, FACS - (Nothing to Disclose)    

Planning Committee/ Editorial Committee

Thomas Baker, MD, FCAP - (Nothing to Disclose)            
Jill Dietz, MD, MHCM, FACS- Cyduct Diagnostics, Peace Medical LLC, Options (currently no value), N/A
Laurie Kirstein, MD, FACS - (Nothing to Disclose)            
Denise Mammolito, MD, FACS - (Nothing to Disclose)            
Alexander Olawaiye, MD, FACS, MRCOG, FACOG     -AstraZeneca, Corcept, Therapeutics ,GSK, Merck, Elsai
,Dalichi Sankyo, Honorarium for advisory board meetings , Research grant, Honorarium for advisory board meetings, Honorarium for advisory board meetings, Honorarium for advisory board meetings 
,Honorarium for advisory board meetings , Advisory board meetings, Research, Advisory board meetings
,Advisory board meetings, Advisory board meetings, Advisory board meetings
Rebecca Snyder, MD, FACS - (Nothing to Disclose)            
Kimberly Yee, MD, FACS    - (Nothing to Disclose)            
Ronald Weigel, MD, FACS - (Nothing to Disclose)            
Mehra Golshan, MD, MBA, FACS - (Nothing to Disclose)        
Jane Meisel, MD - Pfizer, Olema, Sermonix, Astrazeneca, Novartis, Puma, Seagen, Genentech, consulting GSK, institutional research funding and consulting honoraria, consulting honoraria, consultant and servicing as institutional PI of trials
Mediget Teshome, MD, FACS - endomagnetics    travel/accommodations for TBCC22 conference    speaker
Elizabeth Wick, MD, FACS - (Nothing to Disclose)        
Anthony Yang, MD, FACS - (Nothing to Disclose)            
Katherine Yao, MD, FACS - (Nothing to Disclose)            
Judy Boughey, MBBChir, FACS - Cairns Surgical, SymBioSys, Physicians Education Resource (PER)
PeerView, EndoMag, research support to my institution for clinical trial, financial support for time spent on data safety monitoring committee, royalty share for co-developed IP, honorarium, honorarium
Honorarium, Co-PI, member of DSMC, collaboration speaker at educational conference, speaker at educational conference, speaker at educational conference

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American College of Surgeons and ACGME Logos

CME Credit Claiming Information

All learners must complete the course evaluation in order to claim a CME Certificate.  Participants may only claim a maximum of 3.5 AMA PRA Category 1 Credits™.

A Certificate of Completion will be awarded for this course. 
3.5 continuing education credits for #2024-005 will be provided from National Cancer Registrars Association (NCRA).
ACS Cancer Programs is an approved provider by the California Board of Registered Nursing, provider #CEP17437, for 3.5 contact hours. 

Available Credit

  • 3.50 AMA PRA Category 1 Credit™
  • 3.50 CE Contact hours
  • 3.50 Certificate of Completion

Price

Cost:
$100.00
Please login or register to take this course.